跳转至内容
Merck
所有图片(1)

Key Documents

MABC1639

Sigma-Aldrich

Anti-phospho-BRCA1 (Ser114) Antibody, clone 3C10G8

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
NACRES:
NA.74

生物源

mouse

品質等級

共軛

unconjugated

抗體表格

purified antibody

抗體產品種類

primary antibodies

無性繁殖

3C10G8, monoclonal

分子量

calculated mol wt 207.72 kDa
observed mol wt ~30 kDa

純化經由

using protein G

物種活性

human

物種活性(以同源性預測)

monkey

包裝

antibody small pack of 100 μL

技術

immunocytochemistry: suitable
immunofluorescence: suitable
immunoprecipitation (IP): suitable
western blot: suitable

同型

IgG1κ

表位序列

N-terminal

Protein ID登錄號

UniProt登錄號

運輸包裝

2-8°C

目標翻譯後修改

phosphorylation (pSer114)

基因資訊

human ... BRCA1(672)

一般說明

Breast cancer type 1 susceptibility protein (UniProt: P38398; also known as EC:2.3.2.27, RING finger protein 53, RING-type E3 ubiquitin transferase BRCA1) is encoded by the BRCA1 (also known as RNF53) gene (Gene ID: 672) in human. BRCA1 and BRCA2 are important in maintaining genomic stability by promoting efficient and precise repair of double-strand breaks. BRCA1 is expressed in all cells and plays a broader role in various cellular processes in response to DNA damage. It promotes the protection of nascent DNA at stalled replication forks independently of the canonical BRCA1-PALB2 interaction. Its recruitment to DNA damage sites is mediated by ABRAXAS1 and the BRCA1-A complex. BRCA1 contains two BRCT domains (aa 1642-1736 and 1756-1855) that recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1 recruits BRCA1 at DNA damage sites. BRCA1 is reported to exist as a heterodimeric complex with BARD1, a structurally related protein that also contains a N-terminal RING-finger domain and two C-terminal BRCT motifs. This heterodimer regulates the localization and loading of RAD51 at break sites through PALB2-BRCA2. Their association is mediated through their respective RING domains, and together they exhibit E3 ubiquitin ligase activity, which can be disrupted by mutations within the RING domain of BRCA1. BRCA1 and BARD1 are shown to be phosphorylated at residues that are located close to the site of interaction between BARD1 and RAD51 (Ser148 on BARD1 and Ser114 on BRCA1) and Ser114 phosphorylation promotes BRCA1 interaction with PIN1. PIN1 increases interactions between the BRCA1-BARD1 complex and RAD51 resulting in recruitment of RAD51 to stalled replication forks and enhance protection of the nascent DNA strand. Cells lacking BRCA1 show defects in DNA repair by homologous recombination. Mutations in BRCA1 gene have been linked to breast and ovarian cancers. A vast majority of inherited breast cancers result from mutations in the BRCA 1 gene. Male subjects with BRCA1 mutations exhibit about 3-fold increase in risk of prostate cancer. (Ref.: Daza-Martin, M., et al. (2019). Nature. 571(7766); 521-527; Gudumundsdottir, K., and Ashworth, A. (2006). Oncogene 25; 5864-5874).

特異性

Clone 3C10G8 is a mouse monoclonal antibody that specifically detects BRCA1 phosphorylated on serine 114.

免疫原

KLH-conjugated linear peptide corresponding to 14 amino acids surrounding phosphoserine 114 from the N-terminal region of human BRCA1.

應用

Quality Control Testing

Evaluated by Western Blotting with a construct containing GST-tagged recombinant fragment of phosphorylated BRCA1.

Western Blotting Analysis (WB): A 1:500 dilution of this antibody detected a construct containing GST-tagged recombinant BRCA1 fragment phosphorylated on Serine 114 but did not react with non-phosphorylated construct. (BRCA1 construct: Courtesy of Dr. Jesse Rinehart, Yale University, School of Medicine).

Tested Applicaitons

Western Blotting Analysis: A representative lot detected phospho-BRCA1 (Ser114) in Western Blotting applications (Daza-Martin, M., et al. (2019). Nature.;571(7766):521-527).

Immunocytochemistry Analysis: A representative lot detected phospho-BRCA1 (Ser114) in Immunocytochemistry applications (Daza-Martin, M., et al. (2019). Nature.;571(7766):521-527).

Immunofluorescence Analysis: A representative lot detected phospho-BRCA1 (Ser114) in Immunofluorescence applications (Daza-Martin, M., et al. (2019). Nature.;571(7766):521-527).

Immunoprecipitation Analysis: A representative lot immunoprecipitated phospho-BRCA1 (Ser114) in Immunoprecipitation applications (Daza-Martin, M., et al. (2019). Nature.;571(7766):521-527).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-phospho-BRCA1 (Ser114), clone 3C10G8, Cat. No. MABC1639, is a mouse monoclonal antibody that detects BRCA1 phosphorylated on serine 114 and is tested in Immunocytochemistry, Immunofluorescence, Immunoprecipitation, and Western Blotting.

外觀

Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

儲存和穩定性

Recommend storage at +2°C to +8°C. For long term storage antibodies can be kept at -20°C. Avoid repeated freeze-thaws.

其他說明

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门